Therefore, it can be hypothesized that the increased VEGF-A levels in the serum of patients with metastatic RCC favors the recruitment at the tumor site of VEGFR-1 positive immunosuppressive myeloid cells which contribute to immune escape and neoangiogenesis. This evidence concerns the gene VEGFA and neoplasm.